Skip to main content
SpringerLink
Log in

The Canadian labels for branded flouroquinolones [Avelox, Cipro, Cipro XL and Levaquin] have been revised to reinforce the warning

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Association of fluoroquinolone antibiotics (AVELOX, CIPRO, CIPRO XL, and LEVAQUIN) with worsening of symptoms of myasthenia gravis in patients with myasthenia gravis. Internet Document: [2 pages], 9 Mar 2012. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Canadian labels for branded flouroquinolones [Avelox, Cipro, Cipro XL and Levaquin] have been revised to reinforce the warning. React. Wkly. 1394, 4 (2012). https://doi.org/10.2165/00128415-201213940-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00012

Keywords

Search

Navigation